bimzelx
ucb pharma s.a. - bimekizumab - psoriaza - imunosupresivi - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
duloksetin actavis 40 mg trde gastrorezistentne kapsule
actavis group ptc ehf. - duloksetin - gastrorezistentna kapsula, trda - duloksetin 40 mg / 1 kapsula - duloksetin
duloksetin actavis 20 mg trde gastrorezistentne kapsule
actavis group ptc ehf. - duloksetin - gastrorezistentna kapsula, trda - duloksetin 20 mg / 1 kapsula - duloksetin
aritavi 60 mg trde gastrorezistentne kapsule
actavis group ptc ehf. - duloksetin - gastrorezistentna kapsula, trda - duloksetin 60 mg / 1 kapsula - duloksetin
aritavi 30 mg trde gastrorezistentne kapsule
actavis group ptc ehf. - duloksetin - gastrorezistentna kapsula, trda - duloksetin 30 mg / 1 kapsula - duloksetin
kaftrio
vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cistična fibroza - drugi proizvodi dihal - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
nicorette invisipatch 10 mg/16 ur transdermalni obliži
mcneil ab - nikotin - transdermalni obliž - nikotin 15,75 mg / 1 obliž - nikotin
aldizem 60 mg tablete
alkaloid - int d.o.o. - diltiazem - tableta - diltiazem 55,15 mg / 1 tableta - diltiazem
aldizem 90 mg tablete
alkaloid - int d.o.o. - diltiazem - tableta - diltiazem 82,73 mg / 1 tableta - diltiazem
operil 0,5 mg/ml kapljice za nos, raztopina
lek d.d. - oksimetazolin - kapljice za nos, raztopina - oksimetazolin 0,44 mg / 1 ml - oksimetazolin